Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Research output: Contribution to journalJournal articleResearchpeer-review

  1. DLG4-related synaptopathy: a new rare brain disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. DOORS syndrome and a recurrent truncating ATP6V1B2 variant

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • GEMO Study Collaborators
View graph of relations

PURPOSE: We assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and BRCA2 pathogenic variant carriers.

METHODS: Retrospective cohort data on 18,935 BRCA1 and 12,339 BRCA2 female pathogenic variant carriers of European ancestry were available. Three versions of a 313 single-nucleotide polymorphism (SNP) BC PRS were evaluated based on whether they predict overall, estrogen receptor (ER)-negative, or ER-positive BC, and two PRS for overall or high-grade serous EOC. Associations were validated in a prospective cohort.

RESULTS: The ER-negative PRS showed the strongest association with BC risk for BRCA1 carriers (hazard ratio [HR] per standard deviation = 1.29 [95% CI 1.25-1.33], P = 3×10-72). For BRCA2, the strongest association was with overall BC PRS (HR = 1.31 [95% CI 1.27-1.36], P = 7×10-50). HR estimates decreased significantly with age and there was evidence for differences in associations by predicted variant effects on protein expression. The HR estimates were smaller than general population estimates. The high-grade serous PRS yielded the strongest associations with EOC risk for BRCA1 (HR = 1.32 [95% CI 1.25-1.40], P = 3×10-22) and BRCA2 (HR = 1.44 [95% CI 1.30-1.60], P = 4×10-12) carriers. The associations in the prospective cohort were similar.

CONCLUSION: Population-based PRS are strongly associated with BC and EOC risks for BRCA1/2 carriers and predict substantial absolute risk differences for women at PRS distribution extremes.

Original languageEnglish
JournalGenetics in medicine : official journal of the American College of Medical Genetics
Volume22
Issue number10
Pages (from-to)1653-1666
Number of pages14
ISSN1098-3600
DOIs
Publication statusPublished - Oct 2020

    Research areas

  • BRCA1/2, breast cancer, genetics, ovarian cancer, PRS

ID: 61369930